BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 15351965)

  • 21. Genetically modified human umbilical cord blood cells expressing vascular endothelial growth factor and fibroblast growth factor 2 differentiate into glial cells after transplantation into amyotrophic lateral sclerosis transgenic mice.
    Rizvanov AA; Guseva DS; Salafutdinov II; Kudryashova NV; Bashirov FV; Kiyasov AP; Yalvaç ME; Gazizov IM; Kaligin MS; Sahin F; Mukhamedyarov MA; Palotás A; Islamov RR
    Exp Biol Med (Maywood); 2011 Jan; 236(1):91-8. PubMed ID: 21163822
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS.
    Storkebaum E; Lambrechts D; Dewerchin M; Moreno-Murciano MP; Appelmans S; Oh H; Van Damme P; Rutten B; Man WY; De Mol M; Wyns S; Manka D; Vermeulen K; Van Den Bosch L; Mertens N; Schmitz C; Robberecht W; Conway EM; Collen D; Moons L; Carmeliet P
    Nat Neurosci; 2005 Jan; 8(1):85-92. PubMed ID: 15568021
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuroprotection of ischemic brain by vascular endothelial growth factor is critically dependent on proper dosage and may be compromised by angiogenesis.
    Manoonkitiwongsa PS; Schultz RL; McCreery DB; Whitter EF; Lyden PD
    J Cereb Blood Flow Metab; 2004 Jun; 24(6):693-702. PubMed ID: 15181377
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Adeno-associated viral-vector-mediated hypoxia-inducible vascular endothelial growth factor gene expression attenuates ischemic brain injury after focal cerebral ischemia in mice.
    Shen F; Su H; Fan Y; Chen Y; Zhu Y; Liu W; Young WL; Yang GY
    Stroke; 2006 Oct; 37(10):2601-6. PubMed ID: 16946160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia.
    Li Y; Hazarika S; Xie D; Pippen AM; Kontos CD; Annex BH
    Diabetes; 2007 Mar; 56(3):656-65. PubMed ID: 17327433
    [TBL] [Abstract][Full Text] [Related]  

  • 26. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia.
    Sun Y; Jin K; Xie L; Childs J; Mao XO; Logvinova A; Greenberg DA
    J Clin Invest; 2003 Jun; 111(12):1843-51. PubMed ID: 12813020
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Vascular wall maturation and prolonged angiogenic effect by endothelial-specific platelet-derived growth factor expression.
    Levanon K; Varda-Bloom N; Greenberger S; Barshack I; Goldberg I; Orenstein A; Breitbart E; Shaish A; Harats D
    Pathobiology; 2006; 73(3):149-58. PubMed ID: 17085959
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Intrathecal transplantation of human neural stem cells overexpressing VEGF provide behavioral improvement, disease onset delay and survival extension in transgenic ALS mice.
    Hwang DH; Lee HJ; Park IH; Seok JI; Kim BG; Joo IS; Kim SU
    Gene Ther; 2009 Oct; 16(10):1234-44. PubMed ID: 19626053
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intrathecal granulocyte colony-stimulating factor modulate glial cell line-derived neurotrophic factor and vascular endothelial growth factor A expression in glial cells after experimental spinal cord ischemia.
    Chen CH; Huang SY; Chen NF; Feng CW; Hung HC; Sung CS; Jean YH; Wen ZH; Chen WF
    Neuroscience; 2013 Jul; 242():39-52. PubMed ID: 23548516
    [TBL] [Abstract][Full Text] [Related]  

  • 30. VEGF and angiogenesis in acute and chronic MOG((35-55)) peptide induced EAE.
    Roscoe WA; Welsh ME; Carter DE; Karlik SJ
    J Neuroimmunol; 2009 Apr; 209(1-2):6-15. PubMed ID: 19233483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Critical questions for preclinical trials on safety and efficacy of vascular endothelial growth factor-based therapeutic angiogenesis for ischemic stroke.
    Manoonkitiwongsa PS
    CNS Neurol Disord Drug Targets; 2011 Mar; 10(2):215-34. PubMed ID: 20874695
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular and neuronal effects of VEGF in the nervous system: implications for neurological disorders.
    Carmeliet P; Storkebaum E
    Semin Cell Dev Biol; 2002 Feb; 13(1):39-53. PubMed ID: 11969370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. VEGF-induced BBB permeability is associated with an MMP-9 activity increase in cerebral ischemia: both effects decreased by Ang-1.
    Valable S; Montaner J; Bellail A; Berezowski V; Brillault J; Cecchelli R; Divoux D; Mackenzie ET; Bernaudin M; Roussel S; Petit E
    J Cereb Blood Flow Metab; 2005 Nov; 25(11):1491-504. PubMed ID: 15902195
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reduction of a vascular endothelial growth factor receptor, fetal liver kinase-1, by antisense oligonucleotides induces motor neuron death in rat spinal cord exposed to hypoxia.
    Shiote M; Nagano I; Ilieva H; Murakami T; Narai H; Ohta Y; Nagata T; Shoji M; Abe K
    Neuroscience; 2005; 132(1):175-82. PubMed ID: 15780476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New roles for VEGF in nervous tissue--beyond blood vessels.
    Rosenstein JM; Krum JM
    Exp Neurol; 2004 Jun; 187(2):246-53. PubMed ID: 15144851
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vascular endothelial growth factor counteracts the loss of phospho-Akt preceding motor neurone degeneration in amyotrophic lateral sclerosis.
    Dewil M; Lambrechts D; Sciot R; Shaw PJ; Ince PG; Robberecht W; Van den Bosch L
    Neuropathol Appl Neurobiol; 2007 Oct; 33(5):499-509. PubMed ID: 17854437
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sertoli cells improve survival of motor neurons in SOD1 transgenic mice, a model of amyotrophic lateral sclerosis.
    Hemendinger R; Wang J; Malik S; Persinski R; Copeland J; Emerich D; Gores P; Halberstadt C; Rosenfeld J
    Exp Neurol; 2005 Dec; 196(2):235-43. PubMed ID: 16242126
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [VEGF and central nervous system diseases].
    Zhang LY; Fan YY; Liu Z
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2009 Nov; 38(6):644-8. PubMed ID: 20014493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paradoxical response of VEGF expression to hypoxia in CSF of patients with ALS.
    Moreau C; Devos D; Brunaud-Danel V; Defebvre L; Perez T; Destée A; Tonnel AB; Lassalle P; Just N
    J Neurol Neurosurg Psychiatry; 2006 Feb; 77(2):255-7. PubMed ID: 16421133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuroprotective Effect of Vascular Endothelial Growth Factor on Motoneurons of the Oculomotor System.
    Silva-Hucha S; Pastor AM; Morcuende S
    Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33467517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.